首页> 美国卫生研究院文献>AIDS Research and Human Retroviruses >Drug Resistance Mutations in HIV pol Sequences from Argentinean Patients Under Antiretroviral Treatment: Subtype Gender and Age Issues
【2h】

Drug Resistance Mutations in HIV pol Sequences from Argentinean Patients Under Antiretroviral Treatment: Subtype Gender and Age Issues

机译:来自阿根廷患者抗逆转录病毒治疗的HIV pol序列中的耐药性突变:亚型性别和年龄问题

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We studied drug resistance mutations (DRMs) in 2623 pol sequences. Out of 94,828 amino acid substitutions that were detected, 8749 corresponded to nucleoside reverse transcriptase inhibitor (NRTI), 3765 to nonnucleoside reverse transcriptase inhibitor (NNRTI), and 7141 to protease inhibitor (PI) resistance-associated mutations. The most common DRMs were L10I, I54V, L90M, V82A, A71V, L10V, M46I, M184V, M41L, T215Y, D67N, L210W, K70R, N348I, V118I, K103N, Y181C, G190A, K101E, V108I, L100I, V90I, K101Q, and A98G. As expected, DRMs frequencies depended on viral genotype. The amounts of NRTI and PI resistance mutations among B and BF sequences from children were higher than among sequences from adults. The frequencies of PI and NRTI resistance mutations among B and BF sequences from adult men were higher than among sequences from women. Some of these observations can be explained in light of the available epidemiological information, but some cannot, indicating that further studies are needed to understand the antiretroviral resistance epidemics in Argentina.
机译:我们研究了2623个pol序列中的耐药性突变(DRM)。在检测到的94,828个氨基酸取代中,有8749个对应于核苷逆转录酶抑制剂(NRTI),3765个对应于非核苷逆转录酶抑制剂(NNRTI),以及7141个对应于蛋白酶抑制剂(PI)抗性相关突变。最常见的DRM是L10I,I54V,L90M,V82A,A71V,L10V,M46I,M184V,M41L,T215Y,D67N,L210W,K70R,N348I,V118I,K103N,Y181C,G190A,K101E,V108I,L100I,V90I,K101Q和A98G。不出所料,DRM的频率取决于病毒的基因型。来自儿童的B和BF序列中的NRTI和PI抗性突变的数量高于来自成年人的NRTI和PI抗性突变的数量。成年男性的B和BF序列中PI和NRTI抗性突变的频率高于女性的序列。这些观察中的一些可以根据现有的流行病学信息进行解释,但有些则不能,这表明需要进一步的研究来了解阿根廷的抗逆转录病毒耐药性流行病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号